The present invention relates to peptides, proteins, nucleic acids and cellsfor use inimmunotherapeutic methods. In particular, the present invention relates to theimmunotherapy ofcancer. The present invention furthermore relates to tumor-associated T-cellpeptide epitopes, aloneor in combination with other tumor-associated peptides that can for exampleserve as activepharmaceutical ingredients of vaccine compositions that stimulate anti-tumorimmune responses, orto stimulate T cells ex vivo and transfer into patients. Peptides bound tomolecules of the majorhistocompatibility complex (MHC), or peptides as such, can also be targets ofantibodies, soluble T-cell receptors, and other binding molecules.
